|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Neurochemistry,
Department of Developmental Neurobiology, and
Department of Molecular Biology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, USA
1Correspondence: Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Rd., Staten Island, New York 10314, USA. E-mail: cxgong{at}mail.csi.cuny.edu
Adults with Down syndrome (DS) develop Alzheimer neurofibrillary degeneration in the brain, but the underlying molecular mechanism is unknown. Here, we report that the presence of an extra copy of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A (Dyrk1A) gene due to trisomy 21 resulted in overexpression of Dyrk1A and elevated kinase activity in DS brain. Dyrk1A phosphorylated tau at several sites, and these sites were hyperphosphorylated in adult DS brains. Phosphorylation of tau by Dyrk1A primed its further phosphorylation by glycogen synthase kinase-3β (GSK-3β). Dyrk1A-induced tau phosphorylation inhibited taus biological activity and promoted its self-aggregation. In Ts65Dn mouse brain, an extra copy of the Dyrk1A gene caused increased expression and activity of Dyrk1A and resulted in increased tau phosphorylation. These findings strongly suggest a novel mechanism by which the overexpression of Dyrk1A in DS brain causes neurofibrillary degeneration via hyperphosphorylating tau. Liu, F., Liang, Z., Wegiel, J., Hwang, Y.-W., Iqbal, K., Grundke-Iqbal, I., Ramakrishna, N., Gong, C.-X. Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.
Key Words: tau hyperphosphorylation GSK-3β trisomy 21
This article has been cited by other articles:
![]() |
T. M. E. Scales, S. Lin, M. Kraus, R. G. Goold, and P. R. Gordon-Weeks Nonprimed and DYRK1A-primed GSK3{beta}-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons J. Cell Sci., July 15, 2009; 122(14): 2424 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Wiseman, K. A. Alford, V. L.J. Tybulewicz, and E. M.C. Fisher Down syndrome--recent progress and future prospects Hum. Mol. Genet., April 15, 2009; 18(R1): R75 - R83. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |